Thailand prepares armory of anti-COVID weapons for Songkran battle

13 Sept 21:17 Key points summarised by AI

Thailand confronts a surge in COVID-19 cases and deaths, intensifying its battle against the virus ahead of the high-risk Songkran holiday.
New treatment guidelines prioritize anti-viral medications like Favipiravir for vulnerable groups and early symptomatic cases, while advising against them for asymptomatic or mild infections.
The government is strategically stockpiling 75 million Favipiravir and Molnupiravir tablets and has secured 50,000 courses of Paxlovid, a highly effective new anti-viral, to bolster its treatment arsenal.
Medical experts advise caution with anti-viral drugs due to potential side effects, emphasizing targeted prescription for at-risk patients and noting that booster shots offer similar immune benefits for many.

Thailand News in Brief